Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

Abstract The International Staging System for multiple myeloma recently underwent a second revision (R2-ISS) to include gain/amplification of 1q21 and account for the additive prognostic significance of multiple high-risk features. The phase 3 ICARIA-MM (isatuximab–pomalidomide–dexamethasone vs. pom...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Paul G. Richardson, Aurore Perrot, Joseph Mikhael, Thomas Martin, Meral Beksac, Ivan Spicka, Marcelo Capra, Mattia D’Agostino, Pieter Sonneveld, Kamlesh Bisht, Taro Fukao, Rick Zhang, Keisuke Tada, Christina Tekle, Sandrine Macé, Zandra Klippel, Helgi van de Velde, Philippe Moreau
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Publishing Group 2024-11-01
Serija:	Blood Cancer Journal
Online dostop:	https://doi.org/10.1038/s41408-024-01149-w
Oznake:	Označite Brez oznak, prvi označite!